Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription Articles published in J Neurol Sci Retrieve available abstracts of 123 articles: HTML format Text format

Single Articles

January 2012
1. GRANT WB , Mascitelli L
   Evidence that the north-south gradient of multiple sclerosis may not have disappeared.
   J Neurol Sci. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. TROJAN DA , Kaminska M, Bar-Or A, Benedetti A, et al
   Polysomnographic measures of disturbed sleep are associated with reduced quality of life in multiple sclerosis.
   J Neurol Sci. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. BOES MK , Sosnoff JJ, Socie MJ, Sandroff BM, et al
   Postural control in multiple sclerosis: Effects of disability status and dual task.
   J Neurol Sci. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. MOODIE J , Healy BC, Buckle GJ, Gauthier SA, et al
   Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study.
   J Neurol Sci. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. TENEMBAUM S
   Multiple sclerosis in childhood and adolescence.
   J Neurol Sci. 2011;311S1:S53-S57.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. ZIEMSSEN T
   Symptom management in patients with multiple sclerosis.
   J Neurol Sci. 2011;311S1:S48-S52.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. DALGAS U
   Rehabilitation and multiple sclerosis: hot topics in the preservation of physical functioning.
   J Neurol Sci. 2011;311S1:S43-S47.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. MONTALBAN X
   Review of methodological issues of clinical trials in multiple sclerosis.
   J Neurol Sci. 2011;311S1:S35-S42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SORENSEN PS
   Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis.
   J Neurol Sci. 2011;311S1:S29-S34.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. ELOVAARA I
    Early treatment in multiple sclerosis.
    J Neurol Sci. 2011;311S1:S24-S28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. INGLESE M
    MRI measures of neuroprotection and repair in multiple sclerosis.
    J Neurol Sci. 2011;311S1:S16-S23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MEINL E
    Untapped targets in multiple sclerosis.
    J Neurol Sci. 2011;311S1:S12-S15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
13. MELAMUD L , Golan D, Luboshitzky R, Lavi I, et al
    Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. MECA-LALLANA JE , Balseiro JJ, Lacruz F, Guijarro C, et al
    Spasticity improvement in patients with relapsing-remitting multiple sclerosis switching from interferon-beta to glatiramer acetate: The Escala Study.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. BOESCHOTEN RE , Nieuwenhuis MM, van Oppen P, Uitdehaag BM, et al
    Feasibility and outcome of a web-based self-help intervention for depressive symptoms in patients with multiple sclerosis: A pilot study.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
16. FENG X , Reder NP, Yanamandala M, Hill A, et al
    Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. HUANG J , Xie ZF
    Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: A meta-analysis of case-control studies.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. BERLANGA-TAYLOR AJ , Disanto G, Ebers GC, Ramagopalan SV, et al
    Vitamin D-gene interactions in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. TRIANTAFYLLOU N , Lambrinoudaki I, Thoda P, Andreadou E, et al
    Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. KOCH-HENRIKSEN N , Sorensen PS
    Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the Northern hemisphere?
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. BOSTROM I , Landtblom AM, Lauer K
    An ecological study of industry in a high-risk region of multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. HASAN KM , Walimuni IS, Abid H, Datta S, et al
    Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: Implications for understanding the pathogenesis of multiple sclerosis and consol
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. JAFARI N , Hintzen RQ
    The association between cigarette smoking and multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. FERRETTI G , Bacchetti T
    Peroxidation of lipoproteins in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
25. GARCIA-MONTOJO M , Martinez A, Heras VD, Dominguez-Mozo MI, et al
    Herpesvirus active replication in multiple sclerosis A genetic control?
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. HARRIS VK , Yan QJ, Vyshkina T, Sahabi S, et al
    Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. KIRA JI
    Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: Astrocytopathy as a common denominator in demyelinating disorders.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. FERNANDES DE ABREU DA , Landel V, Feron F
    Seasonal, gestational and postnatal influences on multiple sclerosis: The beneficial role of a vitamin D supplementation during early life.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KHAN O , Bao F, Shah M, Caon C, et al
    Effect of disease-modifying therapies on brain volume in relapsing-remitting multiple sclerosis: Results of a five-year brain MRI study.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
30. DE STEFANO N , Sormani MP, Stubinski B, Blevins G, et al
    Efficacy and safety of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: Further outcomes from the IMPROVE study.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. A M , A A P, M A S, M B, et al
    Evaluation of apoptosis-related genes; Fas (CD94), FasL (CD178) and TRAIL polymorphisms in Iranian multiple sclerosis patients.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. SMITH AM , Walker LA, Freedman MS, Berrigan LI, et al
    Activation patterns in multiple sclerosis on the Computerized Tests of Information Processing.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. WEINSTOCK-GUTTMAN B , Zivadinov R, Ramanathan M
    Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. KARMON Y , Kurzweil A, Lindzen E, Holmlund T, et al
    Gerstmann-Straussler-Scheinker syndrome masquerading multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. VASHEGHANI-FARAHANI A , Sahraian MA, Darabi L, Aghsaie A, et al
    Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. HEFFERNAN KS , Ranadive S, Weikert M, Lane A, et al
    Pulse pressure is associated with walking impairment in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. BETHUNE A , Tipu V, Sled JG, Narayanan S, et al
    Diffusion tensor imaging and cognitive speed in children with multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. AURIEL E , Karni A, Bornstein NM, Nissel T, et al
    Extra-cranial venous flow in patients with multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. CAMINERO A , Bartolome M
    Sleep disturbances in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
40. JARIUS S , Paul F, Franciotta D, Ruprecht K, et al
    Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    J Neurol Sci. 2011;306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. DA SILVA AM , Vilhena E, Lopes A, Santos E, et al
    Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease.
    J Neurol Sci. 2011;306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. BRUCK W , Wegner C
    Insight into the mechanism of laquinimod action.
    J Neurol Sci. 2011;306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. FUJIHARA K
    Neuromyelitis optica and astrocytic damage in its pathogenesis.
    J Neurol Sci. 2011;306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. MOWRY EM
    Vitamin D: Evidence for its role as a prognostic factor in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ACHIRON A , Feldman A, Gurevich M
    Characterization of the multiple sclerosis traits: Nuclear receptors (NR) impaired apoptosis pathway and the role of 1-alpha 25-dihydroxyvitamin D(3).
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. KOURI I , Papakonstantinou S, Bempes V, Vasiliadis HS, et al
    HLA associations with multiple sclerosis in Greece.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. LI L , Matsumoto M, Seabrook TJ, Cojean C, et al
    The effect of FTY720 in the Theiler's virus model of multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. CORREALE J , Ysrraelit MC, Gaitan MI
    Vitamin D-mediated immune regulation in Multiple Sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
49. XUAN C , Zhang BB, Li M, Deng KF, et al
    No association between APOE epsilon 4 allele and multiple sclerosis susceptibility: A meta-analysis from 5472 cases and 4727 controls.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. KERBRAT A , Le Page E, Leray E, Anani T, et al
    Natalizumab and drug holiday in clinical practice: An observational study in very active relapsing remitting Multiple Sclerosis patients.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. CHRISTOPHI GP , Christophi JA, Gruber RC, Mihai C, et al
    Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-beta 1a treated multiple sclerosis patients.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. GONZALEZ SJ , Rojas JI, Redal MA, Patrucco L, et al
    CD24 as a genetic modifier of disease progression in multiple sclerosis in Argentinean patients.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
53. POZZILLI C , Schweikert B, Ecari U, Oentrich W, et al
    Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis - Results of the BetaPlus observational cohort study.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. GIORDANO A , Granella F, Lugaresi A, Martinelli V, et al
    Anxiety and depression in multiple sclerosis patients around diagnosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. SMOLDERS J , Hupperts R, Barkhof F, Grimaldi LM, et al
    Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. CONSTANTINESCU CS , Niepel G, Patterson M, Judd A, et al
    Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: No correlation with fatigue and sleepiness.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. RAMAGOPALAN SV , Guimond C, Dyment DA, Yee IM, et al
    Early life child exposure and the risk of multiple sclerosis: A population based study.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. HELLWIG K , Schimrigk S, Chan A, Epplen J, et al
    A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
59. MATA S , Lolli F
    Neuromyelitis optica: an update.
    J Neurol Sci. 2011;303.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. FRANCIOTTA D , Zardini E, Caporali R, Piccolo L, et al
    Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis.
    J Neurol Sci. 2011;303.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. MOTL RW , McAuley E, Mullen S
    Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. GRABER JJ , Dhib-Jalbut S
    Biomarkers of disease activity in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
63. NEWSOME SD , Wang JI, Kang JY, Calabresi PA, et al
    Quantitative measures detect sensory and motor impairments in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. KIISKI H , Reilly RB, Lonergan R, Kelly S, et al
    Change in PASAT performance correlates with change in P3 ERP amplitude over a 12-month period in multiple sclerosis patients.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. ORTON SM , Ramagopalan SV, Para AE, Lincoln MR, et al
    Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. KIM JE , Kim SM, Ahn SW, Lim BC, et al
    Brain abnormalities in neuromyelitis optica.
    J Neurol Sci. 2011;302.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. PROSPERINI L , Kouleridou A, Petsas N, Leonardi L, et al
    The relationship between infratentorial lesions, balance deficit and accidental falls in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. MANNA I , Liguori M, Valentino P, Vena L, et al
    NOS2A as a candidate gene in Relapsing-Remitting Multiple Sclerosis: A haplotype study using selected subsets of single nucleotide polymorphisms.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
69. LIU Y , Liang P, Duan Y, Jia X, et al
    Brain plasticity in relapsing-remitting multiple sclerosis: Evidence from resting-state fMRI.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. SIGER M , Durko A, Nicpan A, Konarska M, et al
    Discontinuation of interferon beta therapy in multiple sclerosis patients with high pre-treatment disease activity leads to prompt return to previous disease activity.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. PERREN F , Fankhauser L, Thievent B, Pache JC, et al
    Late adult onset of Langerhans cell histiocytosis mimicking glioblastoma multiforme.
    J Neurol Sci. 2011;301.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. HLADIKOVA M , Vasku A, Stourac P, Benesova Y, et al
    Two frequent polymorphisms of angiotensinogen and their association with multiple sclerosis progression rate.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
73. HEALY BC , Engler D, Gholipour T, Weiner H, et al
    Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. KAMINSKA M , Kimoff RJ, Schwartzman K, Trojan DA, et al
    Sleep disorders and fatigue in multiple sclerosis: Evidence for association and interaction.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. SCHREUDER F
    Sunlight and MS.
    J Neurol Sci. 2011;300.
    PubMed     Text format     Related articles   
    
    
    
    
76. KOGA M , Takahashi T, Kawai M, Fujihara K, et al
    A serological analysis of viral and bacterial infections associated with neuromyelitis optica.
    J Neurol Sci. 2011;300.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. SYC SB , Warner CV, Saidha S, Farrell SK, et al
    Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis.
    J Neurol Sci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
78. OLIVER BJ , Kohli E, Kasper LH
    Interferon therapy in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis of the comparative trials.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
79. JARIUS S , Frederikson J, Waters P, Paul F, et al
    Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.
    J Neurol Sci. 2010;298.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. OZYEMISCI-TASKIRAN O
    Subjective and objective assessment of fatigue.
    J Neurol Sci. 2010;298.
    PubMed     Text format     Related articles   
    
    
    
    
81. VUKUSIC S , Ionescu I, El-Etr M, Confavreux C, et al
    Re. Multiple sclerosis and progestins: A comment to POPART'MUS.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
82. LEITNER H
    Multiple sclerosis and progestins: A comment to POPART'MUS.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
83. EDAN G , Leray E
    A new treatment era in multiple sclerosis: Clinical applications of new concepts.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. WATTAMWAR PR , Baheti NN, Kesavadas C, Nair M, et al
    Evolution and long term outcome in patients presenting with large demyelinating lesions as their first clinical event.
    J Neurol Sci. 2010;297.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. KALINOWSKA-LYSZCZARZ A , Szczucinski A, Pawlak MA, Losy J, et al
    Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. HEESEN C , Solari A, Giordano A, Kasper J, et al
    Decisions on multiple sclerosis immunotherapy: New treatment complexities urge patient engagement.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
87. MIKULKOVA Z , Praksova P, Stourac P, Bednarik J, et al
    Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. QIU W , Raven S, James I, Luo Y, et al
    Spinal cord involvement in multiple sclerosis: A correlative MRI and high-resolution HLA-DRB1 genotyping study.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. GREGORI B , Papazachariadis O, Farruggia A, Accornero N, et al
    A differential color flicker test for detecting acquired color vision impairment in multiple sclerosis and diabetic retinopathy.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. UNAL A , Dursun A, Emre U, Tascilar NF, et al
    MEFV gene mutations in patients with Multiple Sclerosis.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
91. ZAHEDNASAB H , Saadatnia M, Jabalameli MR, Bahreini SA, et al
    The role of MEFV gene mutations in Multiple Sclerosis susceptibility.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
92. MEINL E , Derfuss T, Krumbholz M, Probstel AK, et al
    Humoral autoimmunity in multiple sclerosis.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
93. ROMERO-PINEL L , Pujal JM, Martinez-Yelamos S, Gubieras L, et al
    Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. LASSMANN H
    Pathophysiology of inflammation and tissue injury in multiple sclerosis: What are the targets for therapy.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. ZHANG Y , Metz LM, Yong VW, Mitchell JR, et al
    3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: A 3-year pilot study.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
96. NOZAKI K , Abou-Fayssal N
    High dose cyclophosphamide treatment in Marburg variant multiple sclerosis A case report.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. LU Z , Qiu W, Zou Y, Lv K, et al
    Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica.
    J Neurol Sci. 2010;293.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. URSHANSKY N , Mausner-Fainberg K, Auriel E, Regev K, et al
    Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
99. CLAROS-SALINAS D , Bratzke D, Greitemann G, Nickisch N, et al
    Fatigue-related diurnal variations of cognitive performance in multiple sclerosis and stroke patients.
    J Neurol Sci. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. UNAL A , Dursun A, Emre U, Tascilar NF, et al
     Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients: Is it a susceptibility gene?
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
101. ROGHANI M , Mahboudi F, Saharian MA, Etemadifar M, et al
     Concentrations of nitric oxide metabolites in the serum of Iranian multiple sclerosis patients.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. WHELAN R , Lonergan R, Kiiski H, Nolan H, et al
     Impaired information processing speed and attention allocation in multiple sclerosis patients versus controls: A high-density EEG study.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. TWYMAN C , Berger JR
     A giant MS plaque mimicking PML during natalizumab treatment.
     J Neurol Sci. 2010;291.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. JARIUS S , Probst C, Borowski K, Franciotta D, et al
     Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
     J Neurol Sci. 2010;291.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. FUVESI J , Bencsik K, Losonczi E, Fricska-Nagy Z, et al
     Factors influencing the health-related quality of life in Hungarian multiple sclerosis patients.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
106. LEVENSON V
     Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
107. RADUE EW , Stuart WH, Calabresi PA, Confavreux C, et al
     Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. FILIPPI M , Rocca MA
     Assessing lesion morphology in MS: why does this matter?
     J Neurol Sci. 2010;290.
     PubMed     Text format     Related articles   
     
     
     
     
109. ZAHEDNASAB H , Bahreini SA
     DNA hypomethylation in multiple sclerosis disease.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
110. SCOTT TF , Schramke CJ
     Poor recovery after the first two attacks of multiple sclerosis is associated with poor outcome five years later.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. KINGWELL E , Leung AL, Roger E, Duquette P, et al
     Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
112. MEHTA BK
     New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
113. MATSUSHITA T , Isobe N, Piao H, Matsuoka T, et al
     Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. RAMAGOPALAN SV , Dyment DA, Guimond C, Orton SM, et al
     Childhood cow's milk allergy and the risk of multiple sclerosis: A population based study.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. LIGGETT T , Melnikov A, Tilwalli S, Yi Q, et al
     Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. WEIKERT M , Motl RW, Suh Y, McAuley E, et al
     Accelerometry in persons with multiple sclerosis: Measurement of physical activity or walking mobility?
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. QIU W , Raven S, Wu JS, Carroll WM, et al
     Wedge-shaped medullary lesions in multiple sclerosis.
     J Neurol Sci. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2009
118. BERGER T
     Current therapeutic recommendations in multiple sclerosis.
     J Neurol Sci. 2009;287S1:S37-S45.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. STUVE O
     Knowns and unknowns in the future of multiple sclerosis treatment.
     J Neurol Sci. 2009;287S1:S30-S36.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. ZIPP F
     A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes.
     J Neurol Sci. 2009;287S1:S24-S29.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. LIBLAU R
     Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
     J Neurol Sci. 2009;287S1:S17-S23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. ZWIBEL H
     Health and quality of life in patients with relapsing multiple sclerosis: making the intangible tangible.
     J Neurol Sci. 2009;287S1:S11-S16.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. BOYKO A , Alain Gabbai A
     Recent advances in multiple sclerosis: challenging paradigms.
     J Neurol Sci. 2009;287 Suppl 1:S1.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: